Where is Vitro Biopharma, Inc.'s headquarters located?

Vitro Biopharma, Inc.'s main headquarters is located at 4621 Technology Drive Golden, Colorado 80403 United States.

What is Vitro Biopharma, Inc.'s phone number?

You can contact Vitro Biopharma, Inc.'s main corporate office by phone at +1-303-999-****.

What is Vitro Biopharma, Inc.'s official website and social media links?

Vitro Biopharma, Inc.'s official website is vitrobiopharma.com. Vitro Biopharma, Inc. has social profiles on LinkedIn.

How much revenue does Vitro Biopharma, Inc. generate?

Vitro Biopharma, Inc.'s annual revenue is estimated to be $500K.

How many employees does Vitro Biopharma, Inc. have currently?

Vitro Biopharma, Inc. has approximately 9 employees.

What industry does Vitro Biopharma, Inc. belong to?

Vitro Biopharma, Inc. operates in the Biotechnology Research industry.

What technology does Vitro Biopharma, Inc. use?

Vitro Biopharma, Inc.'s tech stack includes PHP, HSTS, Fusion Ads, yepnope.js, Microsoft 365.

How much funding has Vitro Biopharma, Inc. raised to date?

Vitro Biopharma, Inc. has raised $3M in funding. The last funding round occurred on Oct 19, 2021 for $3M.

When was Vitro Biopharma, Inc. founded?

Vitro Biopharma, Inc. was founded in 1986.

Vitro Biopharma, Inc. Email Formats	Example	Percentage
First@vitrobiopharma.com	John@vitrobiopharma.com	89%
LFirst@vitrobiopharma.com	DJohn@vitrobiopharma.com	4%
LastF@vitrobiopharma.com	DoeJ@vitrobiopharma.com	3%
First.Last@vitrobiopharma.com	John.Doe@vitrobiopharma.com	4%

Vitro Biopharma, Inc.

Biotechnology ResearchColorado, United States2-10 Employees

Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. AlloRx Stem Cell therapy is intended to be an “off-the-shelf” commercialized product that is stored frozen and available for on demand use. Our pipeline includes four core development programs. We intend to initiate our clinical trials for Long COVID and PTHS in late 2022 or 2023. In addition, we are also currently focused on our pre clinical development programs for MS and Lupus/SLE.

Our research products include:
a) Cell Culture Media 
-We offer various formulations of MSCs and primary cell cultures with numerous competitive advantages.
b) Various Cell Lines
-Our cell lines include Umbilical Cord Blood derived MSCs, Adipose derived MSCs, Fluorescent Labeled MSCs, Cancer Associated Fibroblasts (CAFs), and Differentiated MSCs
c) Brain-Grow Technologies
-Neurological and Inflammatory Biomarker Profiling and Nutraceutical Recovery Packages

Insights

Similar companies to Vitro Biopharma, Inc.

Cook Regentec

ATCC

Lonza

Thermo Fisher Scientific

STEMCELL Technologies

MilliporeSigma